|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/138 | (2006.01) |
| A61K 31/222 | (2006.01) | ||
| A61K 31/4025 | (2006.01) | ||
| A61K 31/4178 | (2006.01) | ||
| A61K 31/438 | (2006.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61K 31/4725 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/14 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/26 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 25/30 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C12N 15/09 | (2006.01) |
| (11) | Number of the document | 3061821 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16151747.9 |
| Date of filing the European patent application | 2010-07-21 | |
| (97) | Date of publication of the European application | 2016-08-31 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 213853 P | 2009-07-22 | US | |
| 282658 P | 2010-03-15 | US |
| (72) |
ELENKO, Eric, US
MILLER, Andrew C., US
MURRAY III, Phillip E., US
|
| (73) |
Puretech Health LLC,
501 Boylston Street Suite 6102, Boston, Massachusetts 02116,
US
|
| (54) | COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION |
| COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION |